x min read


Written by
Richard Sandle
Published on
July 4, 2017
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook

In our last review of AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) we noted a string of acquisitions the Company was making to aggressively expand its footprint in the cannabis sector both domestically and internationally. Today we can report that the Company continues to aggressively expand.Before we delve into the details, here is some background for those that are not familiar with the Company. Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as "Aurora Sky", at the Edmonton International Airport, and has acquired, and is undertaking completion of, a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal's West Island. In addition, the company is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis, as well as owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union ("EU"), based in Germany. Aurora's common shares trade on the TSX-V under the symbol "ACB".On June 28, 2017, Aurora Cannabis Inc announced a strategic agreement with WeedMD Inc. (TSX-V: WMD) whereby WeedMD will provide wholesale dried medical cannabis to Aurora, and Aurora will provide best in class patient education services for WeedMD through its cannabis counselling and outreach unit CanvasRx. Terry Booth, Aurora CEO stated:

"This is a win-win relationship benefiting both companies. We are always looking to expand our product offering, both in terms of quantity for sale and new strains, but we will only do so if we are highly confident that the new products meet the industry-leading Aurora Standard. We have been following WeedMD closely since we first met with their team three years ago, and are impressed with their rigorous commitment to Good Production Practices. We therefore believe WeedMD's products will make a strong addition to our product portfolio, and we look forward to building a deeper relationship as both companies continue to expand."

In other news, as of June 29, 2017, Aurora surpassed 16,000 active registered patients, less than 18 months after the Company’s first products went on sale in January of 2016. Registration accelerated in the months of May and June, 2017, adding approximately 3,000 patients. The Company achieved a new monthly record in May 2017 with gross revenue of more than $2.4 million, representing a 38% increase in revenue compared to January 2017. The month of May reflected the first full month in which sales of the Company’s Aurora Drops line of ingestible cannabis oils supplemented sales of dried cannabis. Revenue from the Company’s recent acquisition of Pedanios GmbH will be consolidated into Aurora’s financial results beginning June 1, 2017.In prior reviews we’ve reported on the appointment of new members the the Company’s management team. Most recently, the Company has appointed Debra Wilson as Vice President, Human Resources. Dr. Wilson has more than 20 years of experience in human resources management and administration, and has served in senior HR roles for Alberta organizations including Universal Rail Systems, Inc., Alberta Pension Services, and Afexa Life Sciences. She is also an Instructor for courses in Human Resource Management, Organizational Behaviour, and Applied Research Methods at the Northern Alberta Institute of Technology (NAIT). Dr. Wilson received her PhD in Psychology from Capella University in Minnesota, and her MBA from Royal Roads University in Victoria, B.C. She will be a member of Aurora’s Executive Team, and an officer of the Company.

ACBFF stock has not had much movement since our last review on June 22, 2017, however, shares have been slowly creeping higher. Current market capitalization stands at US$527.40 million, on 393.17 million shares outstanding as of June 15, 2017. We maintain the position that the Aurora's aggressive expansion strategy will pay off in the future. Be sure to check out all of our prior coverage on ACBFF. We will be updating our subscribers as soon as we know more. For the latest updates on ACBFF, sign up below!Image courtesy of Thomas Hawk via FlickrDisclosure: We have no position in ACBFF and have not been compensated for this article.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.